PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Stacey Williams, Vice President, Marketing, Dermavant Shares Insights on New Campaigns for Adults with Plaque Psoriasis

Stacey Williams, Vice President, Marketing, Dermavant Shares Insights on New Campaigns for Adults with Plaque Psoriasis

January 23, 2023

Priothera Reports the First Patients Enrollment of Mocravimod in P-IIb/III Trial (MO-TRANS) for the Treatment of Acute Myeloid Leukemia

Priothera Reports the First Patients Enrollment of Mocravimod in P-IIb/III Trial (MO-TRANS) for the Treatment of Acute Myeloid Leu...

January 23, 2023

HUTCHMED Entered into an Exclusive License Agreement with Takeda to Develop and Commercialize Fruquintinib

HUTCHMED Entered into an Exclusive License Agreement with Takeda to Develop and Commercialize Fruquintinib

January 23, 2023

Ipsen Presents P-III Trial (NAPOLI 3) Results of Onivyde for Metastatic Pancreatic Ductal Adenocarcinoma at ASCO GI 2023

Ipsen Presents P-III Trial (NAPOLI 3) Results of Onivyde for Metastatic Pancreatic Ductal Adenocarcinoma at ASCO GI 2023

January 23, 2023

CardioRenal Systems’ RenalGuard Therapy Device Receives the US FDA’s Breakthrough Device Designation for Cardiac Surgery Associated AKI

CardioRenal Systems’ RenalGuard Therapy Device Receives the US FDA’s Breakthrough Device Designation for Cardiac Surgery Associate...

January 23, 2023

Eli Lilly and Boehringer Ingelheim Report the US FDA’s Acceptance of sNDA for Jardiance (empagliflozin) to Treat Chronic Kidney Disease

Eli Lilly and Boehringer Ingelheim Report the US FDA’s Acceptance of sNDA for Jardiance (empagliflozin) to Treat Chronic Kidney Di...

January 23, 2023

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us